Clinical trial

Study to Explore the Optimal Dosage/Administration in Alzheimer's Disease

NCT01715350

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2012-05-01

PhasePHASE2

Study timeline

Study start (unknown)2012-05-01Date precision: month

Registry last updated2016-04-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Alzheimer's Diseaseunresolved

Interventions

PM012DRUG

PlaceboDRUG

Sponsors & collaborators

VTBIO Co. LTDlead sponsor

ADM Korea Inccollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01715350 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.